VAXXINITY INC-A (VAXX) Stock News

NASDAQ:VAXX - Nasdaq - US92244V1044 - Common Stock - Currency: USD

0.1111 -0.02 (-15.26%)

After market: 0.1107 0 (-0.36%)

VAXX Latest News, Press Relases and Analysis

All

Press Releases

a year ago - By: Vaxxinity, Inc.

Vaxxinity UB-312 Parkinson’s Trial Results Published in Nature Medicine

a year ago - By: Vaxxinity, Inc.

Vaxxinity UB-312 Parkinson’s Trial Results Published in Nature Medicine

a year ago - By: Benzinga - Mentions: SPTS SGBX MRIN SPT ...

Dow Jumps Over 400 Points; US Adds 175,000 Jobs In April

a year ago - By: InvestorPlace - Mentions: CFBK SPT HSDT

Why Is CF Bankshares (CFBK) Stock Down 19% Today?

a year ago - By: InvestorPlace - Mentions: SPT HSDT

Why Is Sprout Social (SPT) Stock Down 32% Today?

a year ago - By: InvestorPlace - Mentions: HSDT

Why Is Vaxxinity (VAXX) Stock Up 39% Today?

a year ago - By: Benzinga

Why Vaxxinity (VAXX) Shares Are Volatile Today

a year ago - By: InvestorPlace - Mentions: OLB MLEC

Why Is Vaxxinity (VAXX) Stock Down 58% Today?

a year ago - By: InvestorPlace - Mentions: HSDT LOCO ARDX OSPN ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

a year ago - By: Vaxxinity, Inc.

Vaxxinity Issues Shareholder Letter

a year ago - By: BusinessInsider

VAXX Stock Earnings: Vaxxinity Beats EPS for Q4 2023

a year ago - By: InvestorPlace

VAXX Stock Earnings: Vaxxinity Beats EPS for Q4 2023

a year ago - By: InvestorPlace - Mentions: NKE TSLA HEPA

Nike Layoffs 2024: What to Know About the Latest Nike Job Cuts

a year ago - By: InvestorPlace - Mentions: HEPA OLB MLEC

Why Is Hepion Pharmaceuticals (HEPA) Stock Down 41% Today?

a year ago - By: InvestorPlace - Mentions: MLEC OLB CSLR SPCB ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

a year ago - By: Vaxxinity, Inc.

Vaxxinity Issues Shareholder Letter

a year ago - By: Vaxxinity, Inc.

Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock

a year ago - By: Vaxxinity, Inc.

Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock

a year ago - By: Vaxxinity, Inc.

Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting

a year ago - By: Vaxxinity, Inc.

Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting

a year ago - By: Vaxxinity, Inc.

Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates

a year ago - By: Vaxxinity, Inc.

Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates

a year ago - By: Vaxxinity, Inc.

Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024

a year ago - By: Vaxxinity, Inc.